Shares of Moderna rose 5.39% to $103.87 at 11:07 EST on Wednesday, following yesterday’s downward trend. The Nasdaq Stock Market is rising 0.06% to $12,044.50, after two successive sessions in a row of gains, on what as yet seems, a somewhat positive trend trading session today.
Moderna’s last close was $98.56, 2.05% under its 52-week high of $106.00.
Moderna’s sales growth is 1271.1% for the current quarter and 5174.8% for the next. The company’s growth estimates for the ongoing quarter is a negative 62.2% and positive 254.3% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $103.87 at 11:07 EST, below its 52-week high of $106.00 and way higher than its 52-week low of $17.68.
Moderna’s worth is way higher than its 50-day moving average of $77.77 and way higher than its 200-day moving average of $70.18.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”